Home > Clinical Trials
Check All Search

Saved trials

Terminated
NCT01342887
Cyclosporine, Pravastatin Sodium, Etoposide, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
6 Enrollment(s)
1 Study location(s)
Interventional (Phase I|Phase II)
Adult Acute Megakaryoblastic Leukemia (M7)
Adult Acute Minimally Differentiated Myeloid Leukemia (M0)
Adult Acute Monoblastic Leukemia (M5a)
Adult Acute Monocytic Leukemia (M5b)
Adult Acute Myeloblastic Leukemia With Maturation (M2)
Adult Acute Myeloblastic Leukemia Without Maturation (M1)
Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities
Adult Acute Myeloid Leukemia With Del(5q)
Adult Acute Myeloid Leukemia With Inv(16)(p13;q22)
Adult Acute Myeloid Leukemia With t(16;16)(p13;q22)
Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
Adult Acute Myelomonocytic Leukemia (M4)
Adult Erythroleukemia (M6a)
Adult Pure Erythroid Leukemia (M6b)
Recurrent Adult Acute Myeloid Leukemia
Completed
NCT01531114
PraSugrel vs TicagrElor in ST-Elevation Myocardial Infarction paTients With Diabetes Mellitus
50 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
ST-Elevation Myocardial Infarction
Completed
NCT00977938
The Dual Antiplatelet Therapy Study (DAPT Study)
25,682 Enrollment(s)
256 Study location(s)
Interventional (Phase IV)
Coronary Artery Disease
Completed
NCT02215993
Sampling P2Y12 Receptor Inhibition With Prasugrel and Ticagrelor in Patients Submitted to Thrombolysis
50 Enrollment(s)
1 Study location(s)
Interventional (Phase IV)
Acute Coronary Syndrome
Platelet Function
Completed
NCT03138759
Effect of Probenecid on Pexidartinib Pharmacokinetics
16 Enrollment(s)
1 Study location(s)
Interventional (Phase I)
Pharmacokinetics in Healthy Volunteers
Completed
NCT01357486
Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis
160 Enrollment(s)
35 Study location(s)
Interventional (Phase II)
Hepatocellular Carcinoma
CHILD B
Completed
NCT02597907
Postoperative Nausea and Vomiting: Ramosetron Plus Aprepitant vs Palonosetron Plus Aprepitant
88 Enrollment(s)
0 Study location(s)
Interventional (Not Applicable)
Postoperative Nausea and Vomiting
Completed
NCT01515345
Individualizing Dual Antiplatelet Therapy After Percutaneous Coronary Intervention - The IDEAL-PCI Registry
1,008 Enrollment(s)
1 Study location(s)
Interventional (Phase III)
Platelet Inhibition
Coronary Stent Implantation